Stockscreener 앱 받기
4.52
0.89%
0.04
전일 마감가:
$4.48
열려 있는:
$4.47
하루 거래량:
3,734
Relative Volume:
0.18
시가총액:
$3.42M
수익:
$208.50K
순이익/손실:
$-6.85M
주가수익비율:
-0.0649
EPS:
-69.6012
순현금흐름:
$-2.92M
1주 성능:
+7.62%
1개월 성능:
-9.60%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$4.3901
$5.0433
1주일 범위
$4.18
$5.0433
52주 변동 폭
$3.38
$7.56
Nexentis Technologies Inc Stock (NXTS) Company Profile
명칭
Nexentis Technologies Inc
전화
972544561349
주소
156 FIFTH AVENUE 10TH FLOOR, NEW YORK
Compare NXTS vs CTVA, NTR, CF, ICL, MOS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NXTS
Nexentis Technologies Inc
|
4.685 | 3.27M | 208.50K | -6.85M | -2.92M | -69.60 |
CTVA
Corteva Inc
|
79.71 | 53.21B | 17.89B | 1.26B | 2.05B | 1.7029 |
NTR
Nutrien Ltd
|
70.25 | 33.66B | 27.83B | 2.42B | 2.21B | 4.9113 |
CF
Cf Industries Holdings Inc
|
121.78 | 18.70B | 7.41B | 2.12B | 1.62B | 11.13 |
ICL
Icl Group Ltd
|
6.59 | 8.34B | 7.15B | 280.00M | 137.88M | 0.1749 |
MOS
Mosaic Company
|
22.78 | 7.15B | 12.05B | 575.40M | -534.60M | 1.6871 |
Nexentis Technologies Inc 주식(NXTS)의 최신 뉴스
Nexentis Technologies (NXTS) Earnings Outlook: Key Metrics for Q2 2025Retail Trader Picks - Newser
Nexentis subsidiary achieves drug discovery milestone By Investing.com - Investing.com South Africa
Nexentis Technologies says MitoCareX Bio achieves drug discovery milestone - TipRanks
Nexentis subsidiary reaches drug discovery milestone - Investing.com
Nexentis subsidiary reaches drug discovery milestone By Investing.com - Investing.com Canada
Nexentis subsidiary achieves drug discovery milestone - Investing.com
Nexentis develops new molecule to potentially tackle hard-to-treat cancers - Stock Titan
Nexentis Technologies (NASDAQ: NXTS) posts Q1 2026 loss, flags going concern risk - Stock Titan
Nexentis Technologies Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Nexentis Technologies Inc. Announces Drug Discovery Milestone Achieved by MitoCareX Utilizing MITOLINE® Platform - Quiver Quantitative
Nexentis Technologies Announces Optimization of Hit - GlobeNewswire
Nexentis Technologies Inc. (NXTS) - Zacks Investment Research
Number of shareholders of Nexentis Technologies Inc. – NASDAQ:NXTS - TradingView
Nexentis Technologies Secures US Trademark Approval for MitoCareX Algorithm Platform MITOLINE - ChemAnalyst
Nexentis Technologies stock jumps on trademark approval - Investing.com
Nexentis subsidiary receives U.S. trademark for drug platform By Investing.com - Investing.com South Africa
Nexentis Technologies stock jumps on trademark approval By Investing.com - Investing.com Nigeria
Nexentis subsidiary receives U.S. trademark for drug platform - Investing.com
Drug discovery firm secures U.S. trademark for its MITOLINE platform - Stock Titan
Nexentis Technologies Announces U.S. Trademark Registration - GlobeNewswire
NXTS (Nexentis Technologies) falls 2.62% after Q2 2025 earnings with no consensus performance benchmarks available.FCF Yield - newser.com
Nexentis Shareholders Approve Reverse Split and Financing Flexibility - The Globe and Mail
Shareholders back Nexentis (NITO) reverse split and equity financing plans - Stock Titan
[EFFECT] Nexentis Technologies Inc. SEC Filing - Stock Titan
NXTS Price History for Nexentis Technologies Stock - Barchart.com
Nexentis Technologies (NXTS) Short Interest & Short Float | Updated Apr 2026 - MarketBeat
NXTS News | NEXENTIS TECHNOLOGIES INC (NASDAQ:NXTS) - ChartMill
Nexentis Technologies Inc. (NXTS) Cash Equivalents (Quarterly) - Zacks Investment Research
Nexentis Technologies (NXTS) Stock: Breaking Downtrend? (Soars) 2026-04-20Beta Signals - Cổng thông tin điện tử tỉnh Lào Cai
Top Nexentis Technologies (NXTS) Competitors 2026 - MarketBeat
Nexentis Technologies (NXTS) Earnings Date and Reports 2026 - MarketBeat
Nexentis Technologies Incmay offer up to $100 million of securitiesSEC filing - marketscreener.com
[S-3] Nexentis Technologies Inc. Shelf Registration Statement - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Nexentis Technologies (NXTS) Institutional Ownership 2026 - MarketBeat
Nexentis Technologies (NXTS) Stock Price, News & Analysis - MarketBeat
Debt to assets ratio of Nexentis Technologies Inc. – LS:A425ME - TradingView — Track All Markets
Total liabilities of Nexentis Technologies Inc. – LS:A425ME - TradingView — Track All Markets
Revenue per share of Nexentis Technologies Inc. – LS:A425ME - TradingView — Track All Markets
Nexentis Technologies Inc. Statistics – LS:A425ME - TradingView
Non-controlling/minority interest of Nexentis Technologies Inc. – LS:A425ME - TradingView — Track All Markets
Enterprise value to EBITDA ratio of Nexentis Technologies Inc. – LS:A425ME - TradingView — Track All Markets
Total debt per share of Nexentis Technologies Inc. – LS:A425ME - TradingView
Net debt of Nexentis Technologies Inc. – LS:A425ME - TradingView — Track All Markets
Tangible book value per share of Nexentis Technologies Inc. – LS:A425ME - TradingView
Preferred dividends of Nexentis Technologies Inc. – LS:A425ME - TradingView
EBIT of Nexentis Technologies Inc. – LS:A425ME - TradingView — Track All Markets
Nexentis Technologies Inc. Balance Sheet – LS:A425ME - TradingView — Track All Markets
Gross profit of Nexentis Technologies Inc. – LS:A425ME - TradingView — Track All Markets
Nexentis Technologies Inc. Cash Flow – LS:A425ME - TradingView — Track All Markets
Dilution adjustment of Nexentis Technologies Inc. – LS:A425ME - TradingView — Track All Markets
Nexentis Technologies Inc (NXTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.80%
3.25%
자본화:
|
볼륨(24시간):